Live Ownership Coverage: Institutional Investors Love Electromed Inc (NYSEMKT:ELMD)

November 21, 2016 - By Marie Mckinney   ·   0 Comments

Live Ownership Coverage: Institutional Investors  Love Electromed Inc (NYSEMKT:ELMD)

Sentiment for Electromed Inc (NYSEMKT:ELMD)

Electromed Inc (NYSEMKT:ELMD) institutional sentiment decreased to 1.4 in 2016 Q2. Its down -0.16, from 1.56 in 2016Q1. The ratio has worsened, as 14 hedge funds increased and started new equity positions, while 9 sold and reduced stakes in Electromed Inc. The hedge funds in our partner’s database reported: 649,918 shares, down from 1.09 million shares in 2016Q1. Also, the number of hedge funds holding Electromed Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 5 Increased: 7 New Position: 7.

Electromed, Inc. develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation therapy in pulmonary care for patients of all ages. The company has a market cap of $38.60 million. The Company’s products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. It has a 18.03 P/E ratio. As of June 30, 2016, the SmartVest System is available in two models: SV2100 and SQL.

About 41,054 shares traded hands. Electromed, Inc. (NYSEMKT:ELMD) has declined 8.89% since April 19, 2016 and is downtrending. It has underperformed by 12.75% the S&P500.

According to Zacks Investment Research, “Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest® Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.”

Teton Advisors Inc. holds 0.03% of its portfolio in Electromed, Inc. for 77,500 shares. Carlson Capital Management owns 14,134 shares or 0.02% of their US portfolio. Moreover, Bridgeway Capital Management Inc has 0.01% invested in the company for 90,000 shares. The New York-based Spark Investment Management Llc has invested 0.01% in the stock. Thompson Davis & Co. Inc., a Virginia-based fund reported 2,000 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 1 insider buy, and 0 selling transactions for $72,232 net activity.

ELMD Company Profile

Electromed, Inc., incorporated on October 16, 1992, develops, makes and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company’s products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. The Firm sells its products to the home healthcare market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis and neuromuscular disease. It also sells its products in acute care settings when the patient is in a post-surgical or intensive care unit, or is admitted for a lung infection brought on by compromised airway clearance. Accordingly, the Company’s sales points of contact include adult pulmonology clinics, cystic fibrosis centers, neuromuscular clinics, pulmonary rehabilitation centers, hospitals and home healthcare centers.

More notable recent Electromed, Inc. (NYSEMKT:ELMD) news were published by: Businesswire.com which released: “Electromed, Inc. to Participate in the Benchmark Micro Cap Discovery …” on November 21, 2016, also Businesswire.com with their article: “Electromed, Inc. to Present at the 5th Annual InvestMNt Conference on August …” published on August 17, 2016, Businesswire.com published: “Electromed, Inc. Names John Kowalczyk Vice President of Sales” on February 29, 2016. More interesting news about Electromed, Inc. (NYSEMKT:ELMD) were released by: Businesswire.com and their article: “Electromed, Inc. Schedules Release of First Quarter Fiscal 2017 Financial …” published on October 25, 2016 as well as Quotes.Wsj.com‘s news article titled: “Electromed Inc. ELMD (US: NYSE MKT)” with publication date: February 11, 2011.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marie Mckinney


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>